[ASND] QoQ Quarter Result on 31-Dec-2016 [#Q4]

Stock
[ASND] Ascendis Pharma A/S
Announcement Date
30-Nov-2016
Financial Year
2016
Quarter
31-Dec-2016 [#Q4]
Profit Trend
QoQ- 9.89%
YoY- -37.12%
Quarter Report
ASND's Result
ASND's Financial Summary
View:
Show?
Quarter Result
30/09/17 30/06/17 31/03/17 31/12/16 30/09/16 30/06/16 31/03/16 CAGR
Revenue 434 444 372 1,043 1,169 1,136 1,258 -50.77%
PBT -34,117 -30,743 -25,153 -16,426 -18,311 -13,359 -20,636 39.77%
Tax -240 -37 -14 22 -57 -74 -118 60.45%
NP -33,877 -30,706 -25,139 -16,448 -18,254 -13,285 -20,518 39.65%
Tax Rate - - - - - - - -
Total Cost 34,311 31,150 25,511 17,491 19,423 14,421 21,776 35.36%
Ratio Analysis
30/09/17 30/06/17 31/03/17 31/12/16 30/09/16 30/06/16 31/03/16 CAGR
NP Margin -7,805.76 -6,915.77 -6,757.80 -1,576.99 -1,561.51 -1,169.45 -1,631.00 183.72%
Per Share
30/09/17 30/06/17 31/03/17 31/12/16 30/09/16 30/06/16 31/03/16 CAGR
EPS -1.04 -0.94 -0.78 -0.51 -0.72 -0.53 -0.82 17.15%
EPS Diluted -1.04 -0.94 -0.78 -0.51 -0.72 -0.53 -0.82 17.15%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.